Michael Green
Michael Green
Verified email at ucla.edu
Title
Cited by
Cited by
Year
What are the functional consequences of neurocognitive deficits in schizophrenia?
MF Green
The American journal of psychiatry, 1996
43341996
Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”?
MF Green, RS Kern, DL Braff, J Mintz
Schizophrenia bulletin 26 (1), 119-136, 2000
34972000
The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity
KH Nuechterlein, MF Green, RS Kern, LE Baade, DM Barch, JD Cohen, ...
American Journal of Psychiatry 165 (2), 203-213, 2008
18162008
Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS
MF Green, RS Kern, RK Heaton
Schizophrenia research 72 (1), 41-51, 2004
15832004
Identification of separable cognitive factors in schizophrenia
KH Nuechterlein, DM Barch, JM Gold, TE Goldberg, MF Green, ...
Schizophrenia research 72 (1), 29-39, 2004
13862004
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial
RSE Keefe, RM Bilder, SM Davis, PD Harvey, BW Palmer, JM Gold, ...
Archives of general psychiatry 64 (6), 633-647, 2007
11952007
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria
MF Green, KH Nuechterlein, JM Gold, DM Barch, J Cohen, S Essock, ...
Biological psychiatry 56 (5), 301-307, 2004
9612004
Training and quality assurance with the Brief Psychiatric Rating Scale:" the drift busters."
J Ventura, MF Green, A Shaner, RP Liberman
International Journal of Methods in Psychiatric Research, 1993
9301993
Social cognition in schizophrenia: an NIMH workshop on definitions, assessment, and research opportunities
MF Green, DL Penn, R Bentall, WT Carpenter, W Gaebel, RC Gur, ...
Schizophrenia bulletin 34 (6), 1211-1220, 2008
9122008
Cognitive impairment and functional outcome in schizophrenia and bipolar disorder
MF Green
Journal of Clinical Psychiatry 67, 3, 2006
8712006
Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure
DE Gard, AM Kring, MG Gard, WP Horan, MF Green
Schizophrenia research 93 (1-3), 253-260, 2007
7622007
Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P)
J Ventura, RP Liberman, MF Green, A Shaner, J Mintz
Psychiatry research 79 (2), 163-173, 1998
6621998
Should schizophrenia be treated as a neurocognitive disorder?
MF Green, KH Nuechterlein
Schizophrenia bulletin 25 (2), 309-319, 1999
6571999
Social cognition in schizophrenia
MF Green, WP Horan, J Lee
Nature Reviews Neuroscience 16 (10), 620-631, 2015
6202015
The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization
RS Kern, KH Nuechterlein, MF Green, LE Baade, WS Fenton, JM Gold, ...
American Journal of Psychiatry 165 (2), 214-220, 2008
6072008
Does risperidone improve verbal working memory in treatment-resistant schizophrenia?
MF Green, BD Marshall Jr, WC Wirshing, D Ames, SR Marder, S McGurk, ...
American Journal of Psychiatry 154 (6), 799-804, 1997
5841997
Biosocial pathways to functional outcome in schizophrenia
J Brekke, DD Kay, KS Lee, MF Green
Schizophrenia research 80 (2-3), 213-225, 2005
5272005
Social cognition in schizophrenia: recommendations from the measurement and treatment research to improve cognition in schizophrenia new approaches conference
MF Green, B Olivier, JN Crawley, DL Penn, S Silverstein
Schizophrenia bulletin 31 (4), 882-887, 2005
5212005
Baseline neurocognitive deficits in the CATIE schizophrenia trial
RSE Keefe, RM Bilder, PD Harvey, SM Davis, BW Palmer, JM Gold, ...
Neuropsychopharmacology 31 (9), 2033-2046, 2006
5192006
A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia
RW Buchanan, M Davis, D Goff, MF Green, RSE Keefe, AC Leon, ...
Schizophrenia bulletin 31 (1), 5-19, 2005
5152005
The system can't perform the operation now. Try again later.
Articles 1–20